These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 111104

  • 1. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW, Jansen W.
    MMW Munch Med Wochenschr; 1979 Jun 22; 121(25):861-4. PubMed ID: 111104
    [Abstract] [Full Text] [Related]

  • 2. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT, Saling E.
    Z Geburtshilfe Perinatol; 1980 Aug 22; 184(4):283-9. PubMed ID: 7008399
    [Abstract] [Full Text] [Related]

  • 3. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H, Lehmann E.
    Arzneimittelforschung; 1978 Aug 22; 28(9):1531-2. PubMed ID: 582552
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B, Molnár L, Demeter J, Túry F.
    Arzneimittelforschung; 1976 Aug 22; 26(10a):1980-4. PubMed ID: 1037229
    [Abstract] [Full Text] [Related]

  • 5. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G, Jacobs P.
    Laryngol Rhinol Otol (Stuttg); 1977 Oct 22; 56(10):860-3. PubMed ID: 144224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H, Parwaresch MR, Mäder C.
    Med Klin; 1977 Jul 08; 72(27):1183-7. PubMed ID: 196168
    [Abstract] [Full Text] [Related]

  • 8. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B, Khunawat P, Patalung BN, Prabhan C.
    J Med Assoc Thai; 1983 May 08; 66(5):269-73. PubMed ID: 6348198
    [No Abstract] [Full Text] [Related]

  • 9. [The computerized electroencephalogram in evaluating the action of vasoactive and eumetabolic drugs in chronic cerebrovascular disorders].
    Martucci N, Bocola V, Mearelli S, Agnoli A.
    Riv Neurol; 1980 May 08; 50(2):73-97. PubMed ID: 6110238
    [Abstract] [Full Text] [Related]

  • 10. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G, Dupont T.
    Lille Med; 1976 Jan 08; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract] [Full Text] [Related]

  • 11. [The therapy of tinnitus resulting from blast injury (author's transl)].
    Jakobs P, Martin G.
    HNO; 1978 Mar 08; 26(3):104-6. PubMed ID: 346541
    [Abstract] [Full Text] [Related]

  • 12. [Isolation and structure determination of metabolites of xantinol from rat urine (author's transl)].
    Tauscher M, Eckhardt G, Geisel B, Credner K.
    Arzneimittelforschung; 1976 Mar 08; 26(7):1342-4. PubMed ID: 1036921
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Xantinol nicotinate in paralytic poliomyelitis.
    Saksena PN, Malik GK, Tandon OP.
    Indian Pediatr; 1979 Dec 08; 16(12):1081-4. PubMed ID: 541073
    [No Abstract] [Full Text] [Related]

  • 15. Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies.
    Afifi AM, Adnan M, Taha M, Amasha ME.
    Curr Med Res Opin; 1979 Dec 08; 6(5):309-13. PubMed ID: 540521
    [Abstract] [Full Text] [Related]

  • 16. [Circulatory effects of xanthinol nicotinate in advanced pregnancy (author's transl)].
    Schwarz R, Retzke U, Lauckner W.
    Zentralbl Gynakol; 1980 Dec 08; 102(8):446-51. PubMed ID: 7456902
    [Abstract] [Full Text] [Related]

  • 17. Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
    Haacke H, Parwaresch MR, Mäder C.
    Atherosclerosis; 1980 Sep 08; 37(1):77-85. PubMed ID: 7426090
    [Abstract] [Full Text] [Related]

  • 18. [Value of complamin and seduxen in the correction of hemodynamic disorders of epileptic children and adolescents].
    Bulakhova LA, Martyniuk VIu.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987 Sep 08; 87(6):858-62. PubMed ID: 3630497
    [Abstract] [Full Text] [Related]

  • 19. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD.
    Med Monatsschr; 1976 Apr 08; 30(4):178-80. PubMed ID: 958145
    [No Abstract] [Full Text] [Related]

  • 20. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR, Kogel H.
    Int J Clin Pharmacol Biopharm; 1976 Mar 08; 13(2):133-8. PubMed ID: 1254378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.